Related Experiment Video
Updated: Aug 7, 2026
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
CD4 regulatory T cells in human cancer pathogenesis
Keith L Knutson1, Mary L Disis, Lupe G Salazar
1Department of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, 342C Guggenheim, 200 First Street SW, Rochester, MN 55905, USA. knutson.keith@mayo.edu
Cancer Immunology, Immunotherapy : CII
|July 5, 2006
Summary
Regulatory T cells (Tregs) are crucial for immune balance but can hinder anti-tumor immunity. New strategies aim to block tumor-associated Tregs, potentially enhancing cancer immune responses without causing autoimmune disease.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Peripheral immune regulation relies on CD4(+) regulatory T cells (Tregs), which can be thymically derived or peripherally induced.
- Tregs are vital for maintaining immune homeostasis by controlling autoreactive cells and mediating immunity to foreign substances.
- Tumors can exploit CD4(+) Tregs to suppress anti-tumor immune responses, impacting cancer progression.
Purpose of the Study:
- To review the biology of human CD4(+) Tregs.
- To discuss the role of Tregs in cancer pathogenesis.
- To explore emerging strategies for inhibiting tumor-associated Tregs.
Main Methods:
- Literature review of human CD4(+) Treg biology.
- Analysis of Treg involvement in malignancy.
- Examination of therapeutic strategies targeting Tregs.
Main Results:
- CD4(+) Tregs play a dual role in immunity, maintaining homeostasis but also facilitating tumor immune evasion.
- Tumor-associated Tregs suppress immune priming and effector functions crucial for anti-tumor responses.
- Targeting tumor-associated Tregs offers a promising approach to enhance cancer immunotherapy.
Conclusions:
- Understanding CD4(+) Treg biology is key to developing effective cancer immunotherapies.
- Inhibiting tumor-associated Tregs may boost the immune system's ability to fight cancer.
- Future strategies focus on Treg-specific inhibition to avoid off-target autoimmune effects.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...